Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Church & Dwight antiperspirants

This article was originally published in The Tan Sheet

Executive Summary

Arm & Hammer Ultra Max antiperspirant/deodorant with "unique time-released baking soda technology" to begin shipping in early February, firm says. Packaging for re-staged line will be larger, more modern than existing offering; advertising/promotional campaign expected to break in May. TV spots supporting C&D's recently launched Arm & Hammer Advance Breath Care system with toothpaste, mouthwash, gum, mints broke Nov. 1; FSI dropped Nov. 4. Ads stress products' "three hour power to keep breath fresher longer." Firm expects line to generate$65 mil. in first-year sales (1"The Tan Sheet" July 16, p. 6)...

You may also be interested in...



Arm & Hammer Advance Breath Care Line To Generate $65 Mil. In First Year

Church & Dwight's four-product Arm & Hammer Advance Breath Care System is expected to generate sales of $65 mil. within a year of its September debut.

Warning Letter Close-Outs – March 2020

The US FDA released five device-related close-out letters in March.

Medicines Must Be Designated As Priority Items, Says IGBA

Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.

Topics

UsernamePublicRestriction

Register

PS093250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel